CF10 inhibits TS at 100-1,000-fold lower concentrations than 5-FU in CRC cells[16-18] and causes extensive Top1-mediated DNA damage to generate increased replication stress, a point of therapeutic vulnerability in CRC cells. The gene discussed is TOP1; the disease is colorectal carcinoma.